186 related articles for article (PubMed ID: 28724986)
1. Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer.
Wang Q; Alshaker H; Böhler T; Srivats S; Chao Y; Cooper C; Pchejetski D
Sci Rep; 2017 Jul; 7(1):5901. PubMed ID: 28724986
[TBL] [Abstract][Full Text] [Related]
2. New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.
Alshaker H; Wang Q; Srivats S; Chao Y; Cooper C; Pchejetski D
Breast Cancer Res Treat; 2017 Oct; 165(3):531-543. PubMed ID: 28695300
[TBL] [Abstract][Full Text] [Related]
3. Development and in vitro evaluation of core-shell type lipid-polymer hybrid nanoparticles for the delivery of erlotinib in non-small cell lung cancer.
Mandal B; Mittal NK; Balabathula P; Thoma LA; Wood GC
Eur J Pharm Sci; 2016 Jan; 81():162-71. PubMed ID: 26517962
[TBL] [Abstract][Full Text] [Related]
4. Poly(lactic-
Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA
ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379
[TBL] [Abstract][Full Text] [Related]
5. Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments.
Ali S; Amin MU; Tariq I; Sohail MF; Ali MY; Preis E; Ambreen G; Pinnapireddy SR; Jedelská J; Schäfer J; Bakowsky U
Int J Nanomedicine; 2021; 16():951-976. PubMed ID: 33603362
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Consequences of PLGA Nanoparticles in Docetaxel Drug Delivery.
Rafiei P; Haddadi A
Pharm Nanotechnol; 2017; 5(1):3-23. PubMed ID: 28948907
[TBL] [Abstract][Full Text] [Related]
7. PLGA nanoparticle-based docetaxel/LY294002 drug delivery system enhances antitumor activities against gastric cancer.
Cai J; Qian K; Zuo X; Yue W; Bian Y; Yang J; Wei J; Zhao W; Qian H; Liu B
J Biomater Appl; 2019 May; 33(10):1394-1406. PubMed ID: 30952195
[TBL] [Abstract][Full Text] [Related]
8. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
9. Alternating block copolymer-based nanoparticles as tools to modulate the loading of multiple chemotherapeutics and imaging probes.
Mattu C; Brachi G; Menichetti L; Flori A; Armanetti P; Ranzato E; Martinotti S; Nizzero S; Ferrari M; Ciardelli G
Acta Biomater; 2018 Oct; 80():341-351. PubMed ID: 30236799
[TBL] [Abstract][Full Text] [Related]
10. A novel targeted multifunctional nanoplatform for visual chemo-hyperthermia synergy therapy on metastatic lymph nodes via lymphatic delivery.
Liu W; Ye X; He L; Cheng J; Luo W; Zheng M; Hu Y; Zhang W; Cao Y; Ran H; Yang L
J Nanobiotechnology; 2021 Dec; 19(1):432. PubMed ID: 34930301
[TBL] [Abstract][Full Text] [Related]
11. Cabazitaxel-conjugated nanoparticles for docetaxel-resistant and bone metastatic prostate cancer.
Hoang B; Ernsting MJ; Tang WS; Bteich J; Undzys E; Kiyota T; Li SD
Cancer Lett; 2017 Dec; 410():169-179. PubMed ID: 28965854
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of acetyl curcumin-loaded core/shell liposome nanoparticles via an electrospray process for drug delivery, and theranostic applications.
Reddy AS; Lakshmi BA; Kim S; Kim J
Eur J Pharm Biopharm; 2019 Sep; 142():518-530. PubMed ID: 31365879
[TBL] [Abstract][Full Text] [Related]
13. Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain.
Gdowski AS; Ranjan A; Sarker MR; Vishwanatha JK
Nanomedicine (Lond); 2017 Sep; 12(17):2083-2095. PubMed ID: 28805551
[TBL] [Abstract][Full Text] [Related]
14. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1.
Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D
Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815
[TBL] [Abstract][Full Text] [Related]
15. Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.
Chen Q; Zhang L; Li L; Tan M; Liu W; Liu S; Xie Z; Zhang W; Wang Z; Cao Y; Shang T; Ran H
J Nanobiotechnology; 2021 Dec; 19(1):449. PubMed ID: 34952587
[TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Core-Shell-Type Lipid-Polymer Hybrid Nanoparticles: Intracellular Trafficking and Relevance for Oral Absorption.
Li Q; Xia D; Tao J; Shen A; He Y; Gan Y; Wang C
J Pharm Sci; 2017 Oct; 106(10):3120-3130. PubMed ID: 28559042
[TBL] [Abstract][Full Text] [Related]
17. Coadministration of chemotherapy and PI3K/Akt pathway treatment with multistage acidity/CathB enzyme-responsive nanocarriers for inhibiting the metastasis of breast cancer.
Zuo T; Li J; Zhang J; Sun L; Liang X; Yang J; Shen Q
Biomater Sci; 2019 Dec; 7(12):5054-5067. PubMed ID: 31552922
[TBL] [Abstract][Full Text] [Related]
18. Effect of different molecular weight and terminal group PLGA on docetaxel nanoparticles: characterization and cytotoxic activity of castration-resistant prostate cancer cells.
Simitcioglu B; Karagoz ID; Ilbasmis-Tamer S; Tamer U
Pharm Dev Technol; 2022 Sep; 27(7):794-804. PubMed ID: 36046958
[TBL] [Abstract][Full Text] [Related]
19. A multifunctional-targeted nanoagent for dual-mode image-guided therapeutic effects on ovarian cancer cells.
Chen C; Sun J; Chen S; Liu Y; Zhu S; Wang Z; Chang S
Int J Nanomedicine; 2019; 14():753-769. PubMed ID: 30718954
[TBL] [Abstract][Full Text] [Related]
20. Anti-CD24 nano-targeted delivery of docetaxel for the treatment of prostate cancer.
Bharali DJ; Sudha T; Cui H; Mian BM; Mousa SA
Nanomedicine; 2017 Jan; 13(1):263-273. PubMed ID: 27565690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
